Loading...

Hiroyuki Yoda, PhD

Title(s)Postdoctoral Scholar, Neurology
SchoolSchool of Medicine
Address1450 Third St
San Francisco CA 94158
Phone415-502-1694
ORCID ORCID Icon0000-0002-5528-8940 Additional info
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Vitamin K3 derivative induces apoptotic cell death in neuroblastoma via downregulation of MYCN expression. Biochem Biophys Rep. 2019 Dec; 20:100701. Yoda H, Nakayama T, Miura M, Toriyama M, Motohashi S, Suzuki T. PMID: 31844686.
      View in: PubMed   Mentions:
    2. PTPRK suppresses progression and chemo-resistance of colon cancer cells via direct inhibition of pro-oncogenic CD133. FEBS Open Bio. 2019 05; 9(5):935-946. Matsushita M, Mori Y, Uchiumi K, Ogata T, Nakamura M, Yoda H, Soda H, Takiguchi N, Nabeya Y, Shimozato O, Ozaki T. PMID: 30947381.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Estimating genome-wide off-target effects for pyrrole-imidazole polyamide binding by a pathway-based expression profiling approach. PLoS One. 2019; 14(4):e0215247. Lin J, Krishnamurthy S, Yoda H, Shinozaki Y, Watanabe T, Koshikawa N, Takatori A, Horton P, Nagase H. PMID: 30964912.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    4. Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma. Cancer Res. 2019 02 15; 79(4):830-840. Yoda H, Inoue T, Shinozaki Y, Lin J, Watanabe T, Koshikawa N, Takatori A, Nagase H. PMID: 30584073.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    5. Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63. PLoS One. 2017; 12(7):e0179884. Ogata T, Nakamura M, Sang M, Yoda H, Hiraoka K, Yin D, Sang M, Shimozato O, Ozaki T. PMID: 28671946.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63. Oncotarget. 2016 Nov 01; 7(44):71937-71950. Ozaki T, Nakamura M, Ogata T, Sang M, Yoda H, Hiraoka K, Sang M, Shimozato O. PMID: 27713122.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    7. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death. Oncogenesis. 2016 Jun 13; 5(6):e233. Nakamura M, Sugimoto H, Ogata T, Hiraoka K, Yoda H, Sang M, Sang M, Zhu Y, Yu M, Shimozato O, Ozaki T. PMID: 27294865.
      View in: PubMed   Mentions:
    8. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Cell Death Discov. 2015; 1:15010. Sugimoto H, Nakamura M, Yoda H, Hiraoka K, Shinohara K, Sang M, Fujiwara K, Shimozato O, Nagase H, Ozaki T. PMID: 27551445.
      View in: PubMed   Mentions:
    9. Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole-imidazole polyamide conjugate. Nat Commun. 2015 Apr 27; 6:6706. Hiraoka K, Inoue T, Taylor RD, Watanabe T, Koshikawa N, Yoda H, Shinohara K, Takatori A, Sugimoto H, Maru Y, Denda T, Fujiwara K, Balmain A, Ozaki T, Bando T, Sugiyama H, Nagase H. PMID: 25913614.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    10. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity. FEBS J. 2015 Jan; 282(1):114-28. Ozaki T, Sugimoto H, Nakamura M, Hiraoka K, Yoda H, Sang M, Fujiwara K, Nagase H. PMID: 25331851.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    11. Vitamin K3 analogs induce selective tumor cytotoxicity in neuroblastoma. Biol Pharm Bull. 2012; 35(4):617-23. Kitano T, Yoda H, Tabata K, Miura M, Toriyama M, Motohashi S, Suzuki T. PMID: 22466570.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    Hiroyuki's Networks
    Concepts (80)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _